Heart valve device sales are booming in Europe

An aging population and greater use of new technology will drive Europe's heart valve device market to grow more than 10% annually through 2016, Millennium Research Group concludes. Countries particularly affected: France, Germany, Italy and the United Kingdom. Greater use of premium-priced transcatheter heart valve devices expand the pool of patients who can undergo heart valve procedures, the analysts argue, noting that continued innovation should bring more competitors into the market place. In addition, countries such as Germany have boosted their reimbursements for new technology, creating a boost in procedures. Millennium also predicts the aging population will fuel growth. Release

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.